Clinical Trial Update: A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral levofloxacin to oral ciprofloxacin for complicated urinary tract infections has completed, assessing safety and effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyelonephritis
• Urinary Tract Infection

Drugs mentioned

• CIPRO (CIPROFLOXACIN)
• Levaquin (levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Urinary Tract Infections, Bacteriuria | Phase 3 | Status: COMPLETED